LENZ

LENZ Therapeutics
LENZ

Overview Fund Activity

66 hedge funds and large institutions have $95.4M invested in LENZ Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 9 closing their positions.

Holders
66
Holders Change
+3
Holders Change %
+4.76%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
21
Reduced
15
Closed
9
Calls
$446K
Puts
$382K
Net Calls
+$64K
Net Calls Change
-$37K

Top Buyers

1
EC
1
EcoR1 Capital
California
$19M
2
PM
2
Prosight Management
Texas
$3.04M
3
AFM
3
Anson Funds Management
Texas
$359K
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$274K
5
Man Group
5
Man Group
United Kingdom
$371K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.71M
2
OM
2
Opaleye Management
Massachusetts
$0
3
BOTOTLSJU
3
Board of Trustees of The Leland Stanford Junior University
California
$1.52M
4
Goldman Sachs
4
Goldman Sachs
New York
$95K
5
Millennium Management
5
Millennium Management
New York
$443K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$0 7 +7 New
SFG
77
Steward Financial Group
Texas
$0 13 +13 New
1 2 3
4